Related Experiment Videos

Chloral hydrate for emergent pediatric procedural sedation: a new look at an old drug

L S Binder1, L A Leake

  • 1Department of Emergency Medicine, Texas Tech University Health Sciences Center, El Paso 79905.

Insights

Chloral hydrate demonstrates safety and effectiveness for pediatric procedural sedation in the emergency department (ED), particularly for children under six years old. This study supports its use for improving procedural cooperation in young patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Clinical Trials

Background:

  • Chloral hydrate is a traditional agent for pediatric procedural sedation.
  • Its efficacy in emergency department (ED) settings for children remains largely undocumented.
  • This study investigates chloral hydrate's utility in the ED environment.

Purpose of the Study:

  • To evaluate the safety and effectiveness of chloral hydrate for procedural sedation in pediatric patients within an emergency department.
  • To compare sedation scores between children receiving chloral hydrate and a control group.
  • To analyze age-related efficacy of chloral hydrate sedation.

Main Methods:

  • A nonrandomized controlled trial involving 95 children (1-10 years) requiring procedural intervention.
  • Exclusion criteria included respiratory depression, somnolence, allergy, trauma, head injury, or abdominal pain.
  • Sedation was assessed using a modified four-point scale, with data analyzed via Mann Whitney U test.

Main Results:

  • The overall sedation score for the chloral hydrate group was 2.86 versus 2.75 for controls (P=0.63).
  • Statistically significant improvements in sedation scores were observed in children younger than 6 years (P<0.0001) and younger than 4 years (P=0.01).
  • No adverse drug effects were reported; mean time to sedation was 42.7 minutes and recovery was 42.0 minutes.

Conclusions:

  • Chloral hydrate is a safe and effective option for pediatric procedural sedation in the emergency department.
  • Its effectiveness is particularly pronounced in younger children (under 6 years).
  • Further research may confirm these findings and establish optimal dosing protocols.

Related Concept Videos